Streetwise Articles

Analysts View Franco-Nevada's Q1 Earnings as Strong Start to 2017
Source: The Gold Report††(5/11/17)
Franco-Nevada's Q1/17 earnings beat expectations and analysts say the company is off to a good start in 2017. More >

Sandstorm Gold's Mariana Acquisition Is Focus for Analysts
Source: The Gold Report††(5/11/17)
The first quarter results for Sandstorm Gold are in and the focus for analysts is on the agreement to acquire Mariana Resources. More >

DURECT and Sandoz Ink $293 Million Deal for POSIMIR
Source: The Life Sciences Report††(5/10/17)
DURECT Corp. and Sandoz AG, a division of Novartis, have signed a development and commercialization agreement for the U.S. for POSIMIR. More >

Kevin Little

3D Signatures' Platform Taps into the Power of the Genome
Source: The Life Sciences Report††(5/10/17)
How fast is my cancer progressing? Does this treatment present my best option for a cure? These two big questions, which determine outcomes for patients with serious diseases such as Hodgkin's lymphoma, prostate cancer and Alzheimer's disease, are addressed by the platform technology in development by 3D Signatures Inc. In this interview with The Life Sciences Report, 3DS's new Chief Scientific Officer, Dr. Kevin Little, describes the TeloView platform, its utility in the marketplace and what makes it a compelling investment. More >

When Will Gold Stocks Take Off?
Source: Tom Beck for The Gold Report††(5/8/17)
Gold stocks are trading at valuations not seen in decades, according to Tom Beck, senior editor of Portfolio Wealth Global. But conditions are ideal for a new gold bull.
More >

Bob Moriarty

Millennium Minerals, Searching for a Greater Fool
Source: Bob Moriarty for The Gold Report††(5/8/17)
Precious metals expert Bob Moriarty updates investors on recent moves by Millennium Minerals in Australia and discusses recent moves in the silver COT reports. More >

Lior Gantz

Gold: A Tsunami of Selling
Source: Lior Gantz for The Gold Report††(5/7/17)
A chain reaction is forming the last great gold stock buying opportunity of the decade, says Lior Gantz, editor of Wealth Research Group. More >

Jack Chan

Jack Chan's Weekly Gold and Silver Market Update
Source: Jack Chan for The Gold Report††(5/6/17)
Technical analyst Jack Chan charts the latest moves in the precious metals markets.
More >

Pretium Is Looking Forward to Bringing In the Gold at Brucejack
Source: The Gold Report††(5/4/17)
Pretium has introduced ore to the commissioning process to prepare for production at its Brucejack mine. More >

Bob Moriarty

Compared to Silver and Platinum, Gold Is Getting Really Expensive
Source: Bob Moriarty for The Gold Report††(5/4/17)
Investors can make money in precious metals without predicting the direction of prices, says Bob Moriarty of 321 Gold, by paying attention to the gold-platinum and gold-silver spreads. More >

UGE International Shines as a Leader in Commercial Solar Market
Source: The Energy Report††(5/3/17)
UGE International is solidifying its position as a leader in the commercial solar market. More >

Elliot Goldstein

The ProMIS of an Alzheimer's Cure
Source: The Life Sciences Report††(5/3/17)
With the impacts of Alzheimer's disease on patients, doctors and the health care industry expected to burgeon over the next decade, ProMIS Neurosciences has developed a preclinical program that targets the root cause of the disease, and also offers the potential to get in on an investment with a double bottom line, says Elliot Goldstein, CEO of ProMIS, in this interview with The Life Sciences Report.
More >

Mesoblast Heart Failure Trial Delivers Positive Interim Results
Source: The Life Sciences Report††(5/3/17)
Mesoblast Ltd., an Australia-based regenerative medicine company currently in a Phase 3 clinical trial in chronic heart failure, has received successful interim data, which prompted the Maxim Group to comment favorably on the study's design and progress. More >

Newest Mining Explorer to Trade on TSX Venture Worth Watching
Source: The Gold Report††(5/3/17)
The latest company to IPO on the TSX Venture Exchange holds an option on the Cervantes property in Sonora, Mexico, located at the intersection of two major mineralized trends. More >

Bob Moriarty

Red Eagle Exploration Expands
Source: Bob Moriarty for The Gold Report††(5/3/17)
Bob Moriarty of 321Gold describes the evolution of the Red Eagle franchise, which has successfully advanced projects in a volatile jurisdiction.
More >

DOE Uranium Reduction Should Help Boost Market
Source: The Energy Report††(5/2/17)
Department of Energy Secretary Rick Perry issued a determination that reduces the amount of uranium the department can transfer in 2017 and 2018; the reduction should give a boost to uranium producers. More >

Michael Ballanger

Why I Use Precious Metals ETFs for Trading and Penny Stocks for Long-Term Holding
Source: Michael J. Ballanger for The Gold Report††(5/1/17)
Precious metals expert Michael Ballanger explains why he trades precious metals using ETFs, but has penny stocks as his long-term holdings. More >

What's Not Up for Gold
Source: Rudi Fronk and Jim Anthony for The Gold Report††(5/1/17)
There is a push/pull in the gold market that is testing the patience of investors, and Rudi Fronk and Jim Anthony, founders of Seabridge Gold, counsel that investors should stay calm. More >

Jack Chan

Jack Chanís Weekly Gold Update: USD and the Precious Metals Market
Source: Jack Chan for The Gold Report††(4/29/17)
Technical analyst Jack Chan charts the latest moves in the precious metals market, including how changes in the USD could affect gold prices.
More >

Avrupa Closes Financing and Options Portuguese Property
Source: The Gold Report††(4/27/17)
Avrupa Minerals, a prospect generator active in Europe, has closed a financing and announced that it has optioned the Alvito project in southern Portugal. More >

Good Epilepsy Data from Zynerba Pharmaceuticals Would Set Stage for Pivotal Trials
Source: The Life Sciences Report††(4/26/17)
Maxim Group noted that data from Zynerba's Phase 2 proof of concept trial will be released in the third quarter; positive data would set the stage for Phase 3 trials. More >

VistaGen's Fast-Acting Antidepressant Targets Multibillion-Dollar Market
Source: The Life Sciences Report††(4/26/17)
Maxim Group recently initiated coverage of VistaGen Therapeutics, citing its progress on development of a fast-acting therapy to treat major depressive disorders. More >

Trial Results Set Up DURECT Corp. for 'Exciting Year'
Source: The Life Sciences Report††(4/26/17)
Positive results in a Phase 1b trial of DURECT Corp.'s candidate for the treatment of nonalcoholic steatohepatitis (NASH), which were presented at the 2017 International Liver Congress, prompted comments from a pair of analysts. More >

Michael Ballanger

Lumber Tariff Could Boost Canadian Gold Miners
Source: Michael J. Ballanger for The Gold Report††(4/26/17)
The tariff the Trump Administration plans to slap on Canadian lumber imports should lead to a further weakening of the Canadian dollar, a move that precious metals expert Michael Ballanger says can only help the bottom line of Canadian gold producers. More >

AudioEye Is Rapidly Making the Internet Accessible to All
Source: Streetwise Reports††(4/25/17)
AudioEye's innovative technology, which makes the internet available to people with disabilities, has led to rapid growth for the company. More >

Showing Results: 26 to 50 of 2446 Prev Next

Notable Quotes

"We initiate with an Outperform on VIVE."
– Josh Jennings, Cowen & Co.
"AVU optioned its Alvito iron oxide-copper-gold project to OZ Minerals."
– Brien Lundin, Gold Newsletter (Jefferson Financial)
"RVX remains gravely undervalued at the current share price."
– Marcel Wijma, The Daily Molecule (Van Leeuwenhoeck Research), Van Leeuwenhoeck Research